Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications

MLA

Fu, Angel, et al. Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications. Jan. 2016. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........82bfbee53d11a62ffbab2184f5aac9ee&authtype=sso&custid=ns315887.

APA

Fu, A., Singh, K., Abunassar, J., Malhotra, N., Le May, M., Labinaz, M., Glover, C., Marquis, J., Froeschl, M., Dick, A., Hibbert, B., Chong, A., & So, D. Y. F. (2016). Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications.

Chicago

Fu, Angel, Kuljit Singh, Joseph Abunassar, Nikita Malhotra, Michel Le May, Marino Labinaz, Christopher Glover, et al. 2016. “Ticagrelor in Triple Antithrombotic Therapy: Predictors of Ischemic and Bleeding Complications,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........82bfbee53d11a62ffbab2184f5aac9ee&authtype=sso&custid=ns315887.